Anzeige
Mehr »
Sonntag, 31.08.2025 - Börsentäglich über 12.000 News
Wie SuperBuzz am Freitag parabolisch durchstartete - und warum das erst der Anfang sein könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PVQK | ISIN: CA03783R1073 | Ticker-Symbol:
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
APPILI THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
APPILI THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur APPILI THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.08.Appili Therapeutics GAAP EPS of -$0.011
14.08.Appili Therapeutics Inc.: Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 202695Submitted two additional U.S. government funding proposals during the quarter, bringing the total proposals to US$137 million Accepted as a new member of U.S. Medical CBRN Defense Consortium, strengthening...
► Artikel lesen
06.08.Appili Therapeutics Inc: Appili releases tularemia vaccine results1
06.08.Appili Therapeutics Inc.: Appili Therapeutics and Colleagues Publish Manuscript Demonstrating Efficacy of ATI-1701 Tularemia Vaccine1
26.06.Appili Therapeutics Inc.: Appili Therapeutics Reports Fiscal Year 2025 Financial and Operational Results911LIKMEZ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL re-launched and commercial sales ongoing Five U.S. government proposals submitted, totalling up to US$125 million HALIFAX, Nova Scotia...
► Artikel lesen
30.05.Stocks in Play: Appili Therapeutics Inc.1
30.05.Appili Therapeutics Inc.: Appili Therapeutics Announces Formal Termination of Arrangement Agreement with Aditxt Inc.281NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, May 30, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink:...
► Artikel lesen
APPILI THERAPEUTICS Aktie jetzt für 0€ handeln
20.05.Appili Therapeutics Inc: Appili to receive termination fee from Aditxt1
19.05.Aditxt to terminate arrangement agreement with Appili Therapeutics1
19.05.Appili Therapeutics Inc.: Appili Therapeutics Provides Update on Arrangement with Aditxt, Inc.253NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, May 19, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink:...
► Artikel lesen
01.05.Appili Therapeutics Inc.: Appili Therapeutics and Colleagues Publish Manuscript on the Prevention and Emergency Response to Tularemia1
28.04.Appili Therapeutics Inc: Appili Therapeutics granted patents in U.S., Mexico1
28.04.Stocks in Play: Appili Therapeutics Inc.-
28.04.Appili Therapeutics Inc.: Appili Therapeutics Announces New Patents Granted for Commercial Stage Asset LIKMEZ164New patents provide additional composition of matter and methods of use claims, strengthening the protection for liquid oral taste-masked reformulation, LIKMEZ New subject matter listed in the U.S....
► Artikel lesen
02.04.Appili Therapeutics Inc: Appili president to join Aditxt's April 4 update2
02.04.Appili Therapeutics Inc.: Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 20252
18.03.Appili Therapeutics Inc: Appili Therapeutics submits U.S. funding applications1
18.03.Stocks in Play: Appili Therapeutics Inc.1
18.03.Appili Therapeutics Inc.: Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update205Four new funding proposals, totalling US$117.5 million, have been submitted for reviewModifications received to U.S. Air Force Academy Cooperative AgreementOutside date for going-private transaction...
► Artikel lesen
14.02.Appili Therapeutics Inc.: Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025720Received overwhelming shareholder support in favour of take-private transaction with Aditxt Advanced key pipeline programs, engaged regulatory authorities on ATI-1801 and preparing ATI-1701 for an...
► Artikel lesen
Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1